Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Therabron Therapeutics Inc.
DescriptionRecombinant human club cell 10kD protein (rhCC10)
Molecular Target Secretoglobin family 1A member 1 (SCGB1A1) (CC10)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationBronchopulmonary dysplasia (BPD)
Indication DetailsPrevent bronchopulmonary dysplasia (BPD)
Regulatory Designation U.S. - Orphan Drug (Prevent bronchopulmonary dysplasia (BPD));
EU - Orphan Drug (Prevent bronchopulmonary dysplasia (BPD))
PartnerEMS S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today